Fundz

Animol Discovery reported raising $4 Million in an initial SEC Form D filing, from an offering of $4 Million

PRIVATEDec 12, 2024

Amount Raised

$4 Million

$4 Million sold, per SEC Form D (first sale Nov 27, 2024)

Round Type

Venture

BostonBiotechnology

Quick answer

Animol raised $4 Million in a funding round, dated November 27, 2024. Animol is based in Boston, Massachusetts, United States.

How much did Animol raise?
Animol raised $4 Million in a funding round on November 27, 2024.
What does Animol do?
Animol is a drug discovery company that leverages the powerful combination of machine learning and DNA-encoded chemical libraries to build a proprietary pipeline of highly innovative pharmaceuticals for veterinary..
Where is Animol based and how big is it?
Animol is based in Boston, Massachusetts, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Animol that raised within 45 days of this round, from Fundz verified event records.

  • Windward Bio raised $200M (Series A) on January 10, 2025.
  • Light Horse Therapeutics raised $62M (Series A) on January 10, 2025.
  • Numab Therapeutics raised $55M (Series C) on January 10, 2025.
  • RhyGaze raised $86M (Series A) on January 10, 2025.
  • Kardigan raised $300M (Series A) on January 10, 2025.
  • Ouro Medicine raised $120M (Series A) on January 10, 2025.

Who to call at Animol, and when

A new round usually means Animol is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Animol raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Animol, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Animol. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Animol

Location

ONE BOSTON PLACE, SUITE 3950

Boston, Massachusetts, United States

About

Animol is a drug discovery company that leverages the powerful combination of machine learning and DNA-encoded chemical libraries to build a proprietary pipeline of highly innovative pharmaceuticals for veterinary patients.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Animol raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Animol's next move

See what Strategic adds

Animol raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.